Pdgfrβ, a mediator of the adipose lineage
Pdgfrβ, a mediator of the adipose lineage
批准号:
9807355
负责人:
Daniel Carl Berry
金额:
$11.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-16 至 2021-05-31
关键词:
AdipocytesAdipose tissueAdultAnatomyBiologyBlood GlucoseBlood VesselsCardiovascular DiseasesCell LineageCellsCellular biologyClinicalCommunicationComorbidityCuesDataDevelopmentDietEmbryoEpidemicFatty acid glycerol estersFutureGenesGeneticGenetic ModelsGoalsHealthHomeostasisHomingInfluentialsInvestigationLeadMalignant NeoplasmsMediatingMediator of activation proteinMentored Research Scientist Development AwardMetabolicMetabolic DiseasesMetabolic dysfunctionMolecularMolecular ProbesNon-Insulin-Dependent Diabetes MellitusObesityObesity EpidemicOrganogenesisOverweightPathway interactionsPatternPharmacologyPhenotypePlatelet-Derived Growth Factor beta ReceptorPopulationPositioning AttributeProcessPropertyPublic HealthResearchResidenciesRiskRoleSignal TransductionSmooth Muscle MyocytesSpecific qualifier valueStimulusTestingTherapeuticTissue ExpansionTissuesblastomere structuredesignin vivoinsightmacrophagenovelobesogenicpostnatalprecursor cellresidenceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Our overall research goal is to understand the cellular and molecular mechanisms governing the adipose
lineage and to understand how these mechanisms become dysfunctional in response to metabolic
diseases. The worldwide epidemic of obesity and secondary negative health consequences such as type
2 diabetes and cardiovascular disease are a significant public health problem. Thus, there is an urgent
need to better understand the mechanisms and molecules that control the formation of adipocytes and
the expansion of white adipose tissue (WAT). WAT is highly plastic and can expand and shrink in
response to various homeostatic cues, pharmacologic agents, and dietary stimuli. One way that WAT
expands is through the formation of new adipocytes. New adipocytes emanate from a perivascular
adipocyte precursor cell (APC) which appears to anatomically and genetically resemble a subset of mural
cells (smooth muscle cells). However, during WAT organogenesis a distinct and lineage separate APC
patterns and forms the tissues. These findings have led to the notion of two distinct APCs, developmental
and adult. During the K01 award period, we discovered that adipose lineage specific disruption of platelet
derived growth factor receptor beta (Pdgfrβ) signaling interferes with adult APC-niche interaction and
communication and renders these APCs non-adipogenic. However, it was unclear if Pdgfrβ mediated
adult APC lineage specification and WAT niche homing. Thus, our research objective is to understand
the cellular and molecular differences between the APCs that develop WAT versus those that maintain
the adult tissue. To answer this objective, we will use unique genetic models that target different APC
populations to continue to probe the role of Pdgfrβ in the adult APC lineage. Our preliminary data herein
suggest that Pdgfrβ is critical for the specification and determination of the adult adipose lineage. For
instance, when Pdgfrβ is deleted within the adult APC population, they are no longer adipogenic and
anatomically and genetically resemble macrophages. These data frame our hypothesis that Pdgfrβ is an
adult adipose lineage determination factor. We propose to test the genetic requirement of Pdgfrβ and
adult APCs in maintaining and expanding WAT (aim 1). Further we propose to explore the molecular
mechanism(s) by which Pdgfrβ controls the adipose lineage and phenomenon by which APCs can form
adipose tissue resident macrophages (aim 2). The successful completion of these studies will provide
new inroads into how the adult APC lineage is specified and determined leading to healthy adipose tissue
formation and expansion. Moreover, these insights into the mechanisms governing adipose lineage
biology may lead to strategies to assist in counteracting obesity and type 2 diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering age-dependent beige adipocyte failure
-
批准号:10589822
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2022
-
负责人:Daniel Carl Berry
-
依托单位:
Cell cycle regulators control adiposity and metabolism
-
批准号:8784402
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2014
-
负责人:Daniel Carl Berry
-
依托单位:
海外基金